Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1994-11-29
pubmed:abstractText
Sixteen different compounds usually considered beta-lactamase stable or representing potential beta-lactam inhibitors and inactivators were tested against the beta-lactamase produced by Mycobacterium fortuitum. The compounds exhibiting the most interesting properties were BRL42715, which was by far the best inactivator, and CGP31608 and ceftazidime, which were not recognized by the enzyme. These compounds thus exhibited adequate properties for fighting mycobacterial infections. Although cloxacillin, dicloxacillin, cefoxitin, and CP65207-2 exhibited poor inhibitory efficiency against the enzyme, they were also rather poor substrates and might be considered potential antimycobacterial agents. By contrast, CGP31523A and ceftamet were good substrates.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7979294-1510395, http://linkedlifedata.com/resource/pubmed/commentcorrection/7979294-1546847, http://linkedlifedata.com/resource/pubmed/commentcorrection/7979294-1952844, http://linkedlifedata.com/resource/pubmed/commentcorrection/7979294-1952873, http://linkedlifedata.com/resource/pubmed/commentcorrection/7979294-2123098, http://linkedlifedata.com/resource/pubmed/commentcorrection/7979294-2302162, http://linkedlifedata.com/resource/pubmed/commentcorrection/7979294-2679370, http://linkedlifedata.com/resource/pubmed/commentcorrection/7979294-3038122, http://linkedlifedata.com/resource/pubmed/commentcorrection/7979294-3105451, http://linkedlifedata.com/resource/pubmed/commentcorrection/7979294-3190195, http://linkedlifedata.com/resource/pubmed/commentcorrection/7979294-352394, http://linkedlifedata.com/resource/pubmed/commentcorrection/7979294-352395, http://linkedlifedata.com/resource/pubmed/commentcorrection/7979294-3691335, http://linkedlifedata.com/resource/pubmed/commentcorrection/7979294-6984651, http://linkedlifedata.com/resource/pubmed/commentcorrection/7979294-7387634
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
38
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1608-14
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
Use of the chromosomal class A beta-lactamase of Mycobacterium fortuitum D316 to study potentially poor substrates and inhibitory beta-lactam compounds.
pubmed:affiliation
Laboratory of Enzymology, University of Liège, Belgium.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't